Iovance Biotherapeutics: Audience

Iovance Biotherapeutics is focused on developing innovative cancer treatments through tumor infiltrating lymphocyte (TIL) therapy and peripheral blood lymphocyte (PBL) therapy. These therapies utilize the patient's own immune cells to target and attack cancer cells effectively.